A

ADC Therapeutics SA

D

ADCT

USD

0.13

(4.2071%)

Market Closed

11,855.00

حجم التداول

-1.59

الربح لكل سهم

-

العائد الربحي

-1.267717

P/E

311,204,789.00

حجم السوق

اليوم

4.2071%

1 اسبوع

9.898%

1 شهر

9.898%

6 اشهر

-31.049%

12 اشهر

308.629%

بداية السنة

92.814%

كل الوقت

0%

أصول ذات صلة

Title:
ADC Therapeutics SA

Sector:

Healthcare

Industry:

Biotechnology

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا